Chemed Corp
NYSE:CHE
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
517.44
650.7
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Chemed Corp
Wall Street
Price Targets
CHE Price Targets Summary
Chemed Corp
According to Wall Street analysts, the average 1-year price target for
CHE
is 676.94 USD
with a low forecast of 639.33 USD and a high forecast of 743.4 USD.
CHE Last Price Targets
Chemed Corp
The latest public price target was made on Nov 5, 2024 by
Frank Morgan
from
RBC Capital
,
who expects
CHE
stock to
rise by 21%
over the next 12 months.
You can read more about this price target by viewing
the article on StreetInsider.
| Analyst | Price Target | Date | Article |
|---|---|---|---|
Frank Morgan
RBC Capital
|
633
USD
Upside 21% |
1 month ago
Nov 5, 2024
|
Chemed (CHE) PT Lowered to $633 at RBC Capital
StreetInsider
|
|
Frank Morgan
RBC Capital
|
697
USD
Upside 33% |
7 months ago
May 21, 2024
|
Chemed (CHE) PT Lowered to $697 at RBC Capital
StreetInsider
|
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is CHE's stock price target?
Price Target
676.94
USD
According to Wall Street analysts, the average 1-year price target for
CHE
is 676.94 USD
with a low forecast of 639.33 USD and a high forecast of 743.4 USD.
What is Chemed Corp's Revenue forecast?
Projected CAGR
7%
For the last 8 years the
compound annual growth rate for
Chemed Corp's revenue is
5%.
The projected
CAGR
for the next 3 years is
7%.
What is Chemed Corp's Operating Income forecast?
Projected CAGR
12%
For the last 8 years the
compound annual growth rate for
Chemed Corp's operating income is
8%.
The projected
CAGR
for the next 3 years is
12%.
What is Chemed Corp's Net Income forecast?
Projected CAGR
13%
For the last 8 years the
compound annual growth rate for
Chemed Corp's net income is
12%.
The projected
CAGR
for the next 3 years is
13%.
You don't have any saved screeners yet
